Brian Burkavage - 11 May 2022 Form 3 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Accounting Officer
Signature
/s/ Brian Burkavage
Issuer symbol
IOBT
Transactions as of
11 May 2022
Net transactions value
$0
Form type
3
Filing time
13 May 2022, 16:39:51 UTC
Previous filing
09 Jun 2021
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IOBT Common Stock 1,500 11 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IOBT Stock Option (Right to Buy) 11 May 2022 Common Stock 53,000 $8.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on 10/29/2022, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney